Viewing Study NCT00181532


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-25 @ 7:25 PM
Study NCT ID: NCT00181532
Status: COMPLETED
Last Update Posted: 2009-06-30
First Post: 2005-09-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
Sponsor: Maastricht Radiation Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module